Peroxynitrite-driven mechanisms in diabetes and insulin resistance - The latest advances

Current Medicinal Chemistry

Volumn 18, Issue 2, 2011, Pages 280-290

  Stadler, K ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Diabetes; Diabetic complications; Insulin resistance; Lipid peroxidation; Nitrotyrosine; Peroxynitrite

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXYNITRITE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SUPEROXIDE;

ARTICLE; CHEMICAL ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DNA DAMAGE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RETINA ISCHEMIA; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXYNITROUS ACID; SUPEROXIDES;

EID: 78751512092     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711794088317     Document Type: Article

References (158)

1. Ischiropoulos, H.; Beckman, J. S., Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest., 2003, 111, 163-169.
2. Lubos, E.; Handy, D. E.; Loscalzo, J. Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci., 2008, 13, 5323-5344.
3. Moncada, S.; Bolanos, J. P. Nitric oxide cell bioenergetics and neurodegeneration. J. Neurochem., 2006, 97, 1676-1689.
4. Pacher, P.; Beckman, J. S.; Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev., 2007, 87, 315-424.
5. Pacher, P.; Szabo, C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol., 2006, 6, 136-141. (Pubitemid 43362126)
6. Schulz, E.; Jansen, T.; Wenzel, P.; Daiber, A.; Munzel, T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid. Redox. Signal., 2008, 10, 1115-1126.
7. Szabo, C.; Ischiropoulos, H.; Radi, R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov., 2007, 6, 662-680.
8. Hasko, G.; Mabley, J. G.; Nemeth, Z. H.; Pacher, P.; Deitch, E. A.; Szabo, C. Poly (ADP-ribose) polymerase is a regulator of chemokine production: relevance for the pathogenesis of shock and inflammation. Mol. Med., 2002, 8, 283-289.
9. Pacher, P.; Obrosova, I. G.; Mabley, J. G.; Szabo, C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr. Med. Chem., 2005, 12, 267-275.
10. Liaudet, L.; Vassalli, G.; Pacher, P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front Biosci., 2009, 14, 4809-4814.
11. Beckman, J. S.; Beckman, T. W.; Chen, J.; Marshall, P. A.; Freeman, B. A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A., 1990, 87, 1620-1624.
12. Huie, R. E.; Padmaja, S. The reaction of no with superoxide. Free. Radic. Res. Commun., 1993, 18, 195-199.
13. Ignarro, L. J. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci. Rep., 1999, 19, 51-71.
14. Ignarro, L. J.; Cirino, G.; Casini, A.; Napoli, C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol., 1999, 34, 879-886.
15. Joshi, M. S.; Ferguson, T. B., Jr.; Han, T. H.; Hyduke, D. R.; Liao, J. C.; Rassaf, T.; Bryan, N.; Feelisch, M.; Lancaster, J. R., Jr. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 10341-10346.
16. Nauser, T.; Koppenol, W. H. The rate constant of the reaction of superoxide with nitrogen monoxide: Approaching the diffusion limit. J. Phys. Chem. A., 2002, 106, 4084-4086.
17. Hogg, N.; Darley-Usmar, V. M.; Wilson, M. T.; Moncada, S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J., 1992, 281, 419-424.
18. Gatti, R. M.; Alvarez, B.; Vasquez-Vivar, J.; Radi, R.; Augusto, O. Formation of spin trap adducts during the decomposition of peroxynitrite. Arch. Biochem. Biophys., 1998, 349, 36-46.
19. Lehnig, M. Radical mechanisms of the decomposition of peroxynitrite and the peroxynitrite-CO (2) adduct and of reactions with L-tyrosine and related compounds as studied by (15) N chemically induced dynamic nuclear polarization. Arch. Biochem. Biophys., 1999, 368, 303-318.
20. *NO2 radicals. Chem. Res. Toxicol., 1998, 11, 712-713.
21. Radi, R. Peroxynitrite reactions and diffusion in biology. Chem. Res. Toxicol., 1998, 11, 720-721.
22. Ischiropoulos, H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys., 1998, 356, 1-11.
23. Ischiropoulos, H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem. Biophys. Res. Commun., 2003, 305, 776-783.
24. Beckman, J. S. Ischaemic injury mediator. Nature, 1990, 345, 27-28.
25. Beckman, J. S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol., 1996, 9, 836-844.
26. Darley-Usmar, V. M.; Hogg, N.; O'Leary, V. J.; Wilson, M. T.; Moncada, S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun., 1992, 17, 9-20.
27. Radi, R.; Peluffo, G.; Alvarez, M. N.; Naviliat, M.; Cayota, A. Unraveling peroxynitrite formation in biological systems. Free. Radic. Biol. Med., 2001, 30, 463-488.
28. Squadrito, G. L.; Pryor, W. A. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free. Radic. Biol. Med., 1998, 25, 392-403.
29. Augusto, O.; Bonini, M. G.; Amanso, A. M.; Linares, E.; Santos, C. C.; De Menezes, S. L. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic. Biol. Med., 2002, 32, 841-859.
30. Denicola, A.; Freeman, B. A.; Trujillo, M.; Radi, R. Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations. Arch. Biochem. Biophys., 1996, 333, 49-58.
31. Lymar, S. V.; Hurst, J. K. Carbon dioxide: physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant? Chem. Res. Toxicol., 1996, 9, 845-850.
32. Radi, R.; Cosgrove, T. P.; Beckman, J. S.; Freeman, B. A. Peroxynitrite-induced luminol chemiluminescence. Biochem. J., 1993, 290, 51-57.
33. Lymar, S. V.; Jiang, Q.; Hurst, J. K. Mechanism of carbon dioxidecatalyzed oxidation of tyrosine by peroxynitrite. Biochemistry, 1996, 35, 7855-7861.
34. Bonini, M. G.; Augusto, O. Carbon dioxide stimulates the production of thiyl, sulfinyl, and disulfide radical anion from thiol oxidation by peroxynitrite. J. Biol. Chem., 2001, 276, 9749-9754.
35. Goldstein, S.; Czapski, G.; Lind, J.; Merenyi, G. Tyrosine nitration by simultaneous generation of (.) NO and O-(2) under physiological conditions. How the radicals do the job. J. Biol. Chem., 2000, 275, 3031-3036.
36. Santos, C. X.; Bonini, M. G.; Augusto, O. Role of the carbonate radical anion in tyrosine nitration and hydroxylation by peroxynitrite. Arch. Biochem. Biophys., 2000, 377, 146-152.
37. Marla, S. S.; Lee, J.; Groves, J. T. Peroxynitrite rapidly permeates phospholipid membranes. Proc. Natl. Acad. Sci. U. S. A., 1997, 94, 14243-14248.
38. Romero, N.; Denicola, A.; Souza, J. M.; Radi, R. Diffusion of peroxynitrite in the presence of carbon dioxide. Arch. Biochem. Biophys., 1999, 368, 23-30.
39. Khairutdinov, R. F.; Coddington, J. W.; Hurst, J. K. Permeation of phospholipid membranes by peroxynitrite. Biochemistry., 2000, 39, 14238-14249.
40. Lopes de Menezes, S.; Augusto, O. EPR detection of glutathionyl and protein-tyrosyl radicals during the interaction of peroxynitrite with macrophages (J774). J. Biol. Chem., 2001, 276, 39879-39884.
41. Denicola, A.; Souza, J. M.; Radi, R. Diffusion of peroxynitrite across erythrocyte membranes. Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 3566-3571.
42. Macfadyen, A. J.; Reiter, C.; Zhuang, Y.; Beckman, J. S. A novel superoxide dismutase-based trap for peroxynitrite used to detect entry of peroxynitrite into erythrocyte ghosts. Chem. Res. Toxicol., 1999, 12, 223-229.
43. Lancaster, J. R., Jr. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem. Res. Toxicol., 2006, 19, 1160-1174.
44. Zhang, H.; Joseph, J.; Feix, J.; Hogg, N.; Kalyanaraman, B. Nitration and oxidation of a hydrophobic tyrosine probe by peroxynitrite in membranes: comparison with nitration and oxidation of tyrosine by peroxynitrite in aqueous solution. Biochemistry, 2001, 40, 7675-7686.
45. Radi, R.; Cassina, A.; Hodara, R.; Quijano, C.; Castro, L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med., 2002, 33, 1451-1464.
46. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27, 1047-1053.
47. Kowluru, R. A. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid. Redox. Signal., 2005, 7, 1581-1587.
48. Kowluru, R. A.; Chan, P. S. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res., 2007, 2007, 43603.
49. Jay, D.; Hitomi, H.; Griendling, K. K. Oxidative stress and diabetic cardiovascular complications. Free Radic. Biol. Med., 2006, 40, 183-192.
50. Mabley, J. G.; Soriano, F. G. Role of nitrosative stress and poly (ADP-ribose) polymerase activation in diabetic vascular dysfunction. Curr. Vasc. Pharmacol., 2005, 3, 247-252.
51. Obrosova, I. G. Diabetes and the peripheral nerve. Biochim. Biophys. Acta, 2009, 1792, 931-940.
52. Obrosova, I. G.; Drel, V. R.; Pacher, P.; Ilnytska, O.; Wang, Z. Q.; Stevens, M. J.; Yorek, M. A. Oxidative-nitrosative stress and poly (ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes, 2005, 54, 3435-3441.
53. Hadjivassiliou, V.; Green, M. H.; James, R. F.; Swift, S. M.; Clayton, H. A.; Green, I. C. Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines. Nitric Oxide, 1998, 2, 429-441.
54. Cunningham, J. M.; Mabley, J. G.; Delaney, C. A.; Green, I. C. The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F. Mol. Cell Endocrinol., 1994, 102, 23-29.
55. Eizirik, D. L.; Delaney, C. A.; Green, M. H.; Cunningham, J. M.; Thorpe, J. R.; Pipeleers, D. G.; Hellerstrom, C.; Green, I. C. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Cell Endocrinol., 1996, 118, 71-83.
56. Fehsel, K.; Jalowy, A.; Qi, S.; Burkart, V.; Hartmann, B.; Kolb, H. Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes, 1993, 42, 496-500.
57. Ha, H. C.; Snyder, S. H. Poly (ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 13978-13982.
58. Radons, J.; Heller, B.; Burkle, A.; Hartmann, B.; Rodriguez, M. L.; Kroncke, K. D.; Burkart, V.; Kolb, H. Nitric oxide toxicity in islet cells involves poly (ADP-ribose) polymerase activation and concomitant NAD+ depletion. Biochem. Biophys. Res. Commun., 1994, 199, 1270-1277.
59. Szabo, C. Roles of poly (ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol. Res., 2005, 52, 60-71.
60. Rabinovitch, A.; Suarez-Pinzon, W. L.; Sorensen, O.; Bleackley, R. C. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS-expressing cells and relationships to cytokines expressed in the islets. Endocrinology, 1996, 137, 2093-2099.
61. Flodstrom, M.; Tyrberg, B.; Eizirik, D. L.; Sandler, S. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes, 1999, 48, 706-713.
62. Suarez-Pinzon, W. L.; Szabo, C.; Rabinovitch, A. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes, 1997, 46, 907-911.
63. Suarez-Pinzon, W. L.; Mabley, J. G.; Strynadka, K.; Power, R. F.; Szabo, C.; Rabinovitch, A. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. J. Autoimmun., 2001, 16, 449-455.
64. Szabo, C.; Mabley, J. G.; Moeller, S. M.; Shimanovich, R.; Pacher, P.; Virag, L.; Soriano, F. G.; Van Duzer, J. H.; Williams, W.; Salzman, A. L.; Groves, J. T. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol. Med., 2002, 8, 571-580.
65. Du, X.; Matsumura, T.; Edelstein, D.; Rossetti, L.; Zsengeller, Z.; Szabo, C.; Brownlee, M. Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest., 2003, 112, 1049-1057.
66. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414, 813-820.
67. Caballero, A. E.; Arora, S.; Saouaf, R.; Lim, S. C.; Smakowski, P.; Park, J. Y.; King, G. L.; Lo Gerfo, F. W.; Horton, E. S.; Veves, A. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes, 1999, 48, 1856-1862.
68. Calles-Escandon, J.; Cipolla, M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev., 2001, 22, 36-52.
69. Da Ros, R.; Assaloni, R.; Ceriello, A. Antioxidant therapy in diabetic complications: what is new? Curr. Vasc. Pharmacol., 2004, 2, 335-341.
70. Obrosova, I. G. Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid. Redox. Signal., 2005, 7, 1543-1552.
71. Coppey, L. J.; Gellett, J. S.; Davidson, E. P.; Yorek, M. A. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radic. Res., 2003, 37, 33-40.
72. Drel, V. R.; Pacher, P.; Vareniuk, I.; Pavlov, I.; Ilnytska, O.; Lyzogubov, V. V.; Tibrewala, J.; Groves, J. T.; Obrosova, I. G. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur. J. Pharmacol., 2007, 569, 48-58.
73. Drel, V. R.; Pacher, P.; Vareniuk, I.; Pavlov, I. A.; Ilnytska, O.; Lyzogubov, V. V.; Bell, S. R.; Groves, J. T.; Obrosova, I. G. Evaluation of the peroxynitrite decomposition catalyst Fe (III) tetramesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int. J. Mol. Med., 2007, 20, 783-792.
74. Nangle, M. R.; Cotter, M. A.; Cameron, N. E. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur. J. Pharmacol., 2004, 502, 143-148.
75. Obrosova, I. G.; Drel, V. R.; Oltman, C. L.; Mashtalir, N.; Tibrewala, J.; Groves, J. T.; Yorek, M. A. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am. J. Physiol. Endocrinol. Metab., 2007, 293, E1645-1655.
76. Obrosova, I. G.; Mabley, J. G.; Zsengeller, Z.; Charniauskaya, T.; Abatan, O. I.; Groves, J. T.; Szabo, C. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J., 2005, 19, 401-403.
77. Vareniuk, I.; Pavlov, I. A.; Drel, V. R.; Lyzogubov, V. V.; Ilnytska, O.; Bell, S. R.; Tibrewala, J.; Groves, J. T.; Obrosova, I. G. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp. Neurol., 2007, 205, 425-436.
78. Julius, U.; Drel, V. R.; Grassler, J.; Obrosova, I. G. Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy. Exp. Clin. Endocrinol. Diabetes, 2009, 117, 72-77.
79. Vareniuk, I.; Pavlov, I. A.; Obrosova, I. G. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia, 2008, 51, 2126-2133.
80. Ilnytska, O.; Lyzogubov, V. V.; Stevens, M. J.; Drel, V. R.; Mashtalir, N.; Pacher, P.; Yorek, M. A.; Obrosova, I. G. Poly (ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes, 2006, 55, 1686-1694.
81. Obrosova, I. G.; Li, F.; Abatan, O. I.; Forsell, M. A.; Komjati, K.; Pacher, P.; Szabo, C.; Stevens, M. J. Role of poly (ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes, 2004, 53, 711-720.
82. Thuraisingham, R. C.; Nott, C. A.; Dodd, S. M.; Yaqoob, M. M. Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int., 2000, 57, 1968-1972.
83. Stadler, K.; Jenei, V.; von Bolcshazy, G.; Somogyi, A.; Jakus, J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic. Biol. Med., 2003, 35, 1240-1251.
84. Kiss, L.; Szabo, C. The pathogenesis of diabetic complications: the role of DNA injury and poly (ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity. Mem. Inst. Oswaldo Cruz, 2005, 100 (Suppl 1), 29-37.
85. Minchenko, A. G.; Stevens, M. J.; White, L.; Abatan, O. I.; Komjati, K.; Pacher, P.; Szabo, C.; Obrosova, I. G. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly (ADP-ribose) polymerase activation. FASEB J., 2003, 17, 1514-1516.
86. Xiao, H.; Li, Y.; Qi, J.; Wang, H.; Liu, K. Peroxynitrite plays a key role in glomerular lesions in diabetic rats. J. Nephrol., 2009, 22, 800-808.
87. Wang, H.; Li, Y.; Liu, H.; Liu, S.; Liu, Q.; Wang, X. M.; Shi, Y.; Duan, H. Peroxynitrite mediates glomerular lesion of diabetic rat via JAK/STAT signaling pathway. J. Endocrinol. Invest., 2009, 32, 844-851.
88. Obrosova, I. G.; Pacher, P.; Szabo, C.; Zsengeller, Z.; Hirooka, H.; Stevens, M. J.; Yorek, M. A. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly (ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes, 2005, 54, 234-242.
89. Drel, V. R.; Pacher, P.; Stevens, M. J.; Obrosova, I. G. Aldose reductase inhibition counteracts nitrosative stress and poly (ADP-ribose) polymerase activation in diabetic rat kidney and high-glucoseexposed human mesangial cells. Free Radic. Biol. Med., 2006, 40, 1454-1465.
90. Ellis, E. A.; Guberski, D. L.; Hutson, B.; Grant, M. B. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide, 2002, 6, 295-304.
91. Kowluru, R. A.; Kanwar, M.; Kennedy, A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp. Diabetes Res., 2007, 2007, 21976.
92. El-Remessy, A. B.; Abou-Mohamed, G.; Caldwell, R. W.; Caldwell, R. B. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest. Ophthalmol. Vis. Sci., 2003, 44, 3135-3143.
93. Marumo, T.; Noll, T.; Schini-Kerth, V. B.; Harley, E. A.; Duhault, J.; Piper, H. M.; Busse, R. Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor. J. Vasc. Res., 1999, 36, 510-515.
94. Shibuki, H.; Katai, N.; Yodoi, J.; Uchida, K.; Yoshimura, N. Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci., 2000, 41, 3607-3614.
95. Obrosova, I. G.; Drel, V. R.; Kumagai, A. K.; Szabo, C.; Pacher, P.; Stevens, M. J. Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia, 2006, 49, 2525-2533.
96. Du, Y.; Smith, M. A.; Miller, C. M.; Kern, T. S. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J. Neurochem., 2002, 80, 771-779.
97. Sugawara, R.; Hikichi, T.; Kitaya, N.; Mori, F.; Nagaoka, T.; Yoshida, A.; Szabo, C. Peroxynitrite decomposition catalyst, FP15, and poly (ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats. Curr. Eye. Res., 2004, 29, 11-16.
98. Obrosova, I. G.; Minchenko, A. G.; Frank, R. N.; Seigel, G. M.; Zsengeller, Z.; Pacher, P.; Stevens, M. J.; Szabo, C. Poly (ADP-ribose) polymerase inhibitors counteract diabetes-and hypoxiainduced retinal vascular endothelial growth factor overexpression. Int. J. Mol. Med., 2004, 14, 55-64.
99. Ceriello, A.; Quagliaro, L.; D'Amico, M.; Di Filippo, C.; Marfella, R.; Nappo, F.; Berrino, L.; Rossi, F.; Giugliano, D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes., 2002, 51, 1076-1082.
100. Cohen, R. A. Role of nitric oxide in diabetic complications. Am. J. Ther., 2005, 12, 499-502.
101. Frustaci, A.; Kajstura, J.; Chimenti, C.; Jakoniuk, I.; Leri, A.; Maseri, A.; Nadal-Ginard, B.; Anversa, P. Myocardial cell death in human diabetes. Circ. Res., 2000, 87, 1123-1132.
102. Pacher, P.; Schulz, R.; Liaudet, L.; Szabo, C. Nitrosative stress and pharmacological modulation of heart failure. Trends. Pharmacol. Sci., 2005, 26, 302-310.
103. Zou, M. H.; Cohen, R.; Ullrich, V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium, 2004, 11, 89-97.
104. Zou, M. H.; Shi, C.; Cohen, R. A. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H (2) receptormediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes, 2002, 51, 198-203.
105. Levrand, S.; Vannay-Bouchiche, C.; Pesse, B.; Pacher, P.; Feihl, F.; Waeber, B.; Liaudet, L. Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic. Biol. Med., 2006, 41, 886-895.
106. Zou, M. H.; Shi, C.; Cohen, R. A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest., 2002, 109, 817-826.
107. Clavreul, N.; Adachi, T.; Pimental, D. R.; Ido, Y.; Schoneich, C.; Cohen, R. A. S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J., 2006, 20, 518-520.
108. Clavreul, N.; Bachschmid, M. M.; Hou, X.; Shi, C.; Idrizovic, A.; Ido, Y.; Pimentel, D.; Cohen, R. A. S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler. Thromb. Vasc. Biol., 2006, 26, 2454-2461.
109. Pacher, P.; Mabley, J. G.; Soriano, F. G.; Liaudet, L.; Komjati, K.; Szabo, C. Endothelial dysfunction in aging animals: the role of poly (ADP-ribose) polymerase activation. Br. J. Pharmacol., 2002, 135, 1347-1350.
110. Pacher, P.; Liaudet, L.; Soriano, F. G.; Mabley, J. G.; Szabo, E.; Szabo, C. The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes, 2002, 51, 514-521.
111. Szabo, C.; Zanchi, A.; Komjati, K.; Pacher, P.; Krolewski, A. S.; Quist, W. C.; Lo Gerfo, F. W.; Horton, E. S.; Veves, A. Poly (ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation, 2002, 106, 2680-2686.
112. Pacher, P.; Liaudet, L.; Mabley, J.; Komjati, K.; Szabo, C. Pharmacologic inhibition of poly (adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure. J. Am. Coll. Cardiol., 2002, 40, 1006-1016.
113. Pacher, P.; Mabley, J. G.; Soriano, F. G.; Liaudet, L.; Szabo, C. Activation of poly (ADP-ribose) polymerase contributes to the endothelial dysfunction associated with hypertension and aging. Int. J. Mol. Med., 2002, 9, 659-664.
114. Pacher, P.; Szabo, C. Role of poly (ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid. Redox. Signal., 2005, 7, 1568-1580.
115. Kajstura, J.; Fiordaliso, F.; Andreoli, A. M.; Li, B.; Chimenti, S.; Medow, M. S.; Limana, F.; Nadal-Ginard, B.; Leri, A.; Anversa, P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes, 2001, 50, 1414-1424.
116. Stadler, K.; Jenei, V.; Somogyi, A.; Jakus, J. Beneficial effects of aminoguanidine on the cardiovascular system of diabetic rats. Diabetes Metab. Res. Rev., 2005, 21, 189-196.
117. Esberg, L. B.; Ren, J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia, 2003, 46, 1419-1427.
118. Pacher, P.; Vaslin, A.; Benko, R.; Mabley, J. G.; Liaudet, L.; Hasko, G.; Marton, A.; Batkai, S.; Kollai, M.; Szabo, C. A new, potent poly (ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging. J. Pharmacol. Exp. Ther., 2004, 311, 485-491.
119. Soriano, F. G.; Pacher, P.; Mabley, J.; Liaudet, L.; Szabo, C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP-ribose) polymerase. Circ. Res., 2001, 89, 684-691.
120. Souza, J. M.; Peluffo, G.; Radi, R. Protein tyrosine nitration-functional alteration or just a biomarker? Free Radic. Biol. Med., 2008, 45, 357-366.
121. Quijano, C.; Hernandez-Saavedra, D.; Castro, L.; McCord, J. M.; Freeman, B. A.; Radi, R. Reaction of peroxynitrite with Mnsuperoxide dismutase. Role of the metal center in decomposition kinetics and nitration. J. Biol. Chem., 2001, 276, 11631-11638.
122. MacMillan-Crow, L. A.; Crow, J. P.; Kerby, J. D.; Beckman, J. S.; Thompson, J. A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. U. S. A., 1996, 93, 11853-11858.
123. Hodara, R.; Norris, E. H.; Giasson, B. I.; Mishizen-Eberz, A. J.; Lynch, D. R.; Lee, V. M.; Ischiropoulos, H. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. J. Biol. Chem., 2004, 279, 47746-47753.
124. Vadseth, C.; Souza, J. M.; Thomson, L.; Seagraves, A.; Nagaswami, C.; Scheiner, T.; Torbet, J.; Vilaire, G.; Bennett, J. S.; Murciano, J. C.; Muzykantov, V.; Penn, M. S.; Hazen, S. L.; Weisel, J. W.; Ischiropoulos, H. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J. Biol. Chem., 2004, 279, 8820-8826.
125. Cassina, A. M.; Hodara, R.; Souza, J. M.; Thomson, L.; Castro, L.; Ischiropoulos, H.; Freeman, B. A.; Radi, R. Cytochrome c nitration by peroxynitrite. J. Biol. Chem., 2000, 275, 21409-21415.
126. Gole, M. D.; Souza, J. M.; Choi, I.; Hertkorn, C.; Malcolm, S.; Foust, R. F., 3rd; Finkel, B.; Lanken, P. N.; Ischiropoulos, H. Plasma proteins modified by tyrosine nitration in acute respiratory distress syndrome. Am. J. Physiol. Lung. Cell. Mol. Physiol., 2000, 278, L961-967.
127. Pacher, P.; Szabo, C. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease. Am. J. Pathol., 2008, 173, 2-13.
128. Drel, V. R.; Xu, W.; Zhang, J.; Kador, P. F.; Ali, T. K.; Shin, J.; Julius, U.; Slusher, B.; El-Remessy, A. B.; Obrosova, I. G. Poly (ADP-ribose) polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats. Invest. Ophthalmol. Vis. Sci., 2009, 50, 1778-1790.
129. Agardh, C. D.; Agardh, E.; Obrosova, I. G.; Smith, M. L. The aldose reductase inhibitor fidarestat suppresses ischemia-reperfusioninduced inflammatory response in rat retina. Pharmacology, 2009, 84, 257-263.
130. Drel, V. R.; Xu, W.; Zhang, J.; Pavlov, I. A.; Shevalye, H.; Slusher, B.; Obrosova, I. G. Poly (Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy. Endocrinology, 2009, 150, 5273-5283.
131. Shevalye, H.; Stavniichuk, R.; Xu, W.; Zhang, J.; Lupachyk, S.; Maksimchyk, Y.; Drel, V. R.; Floyd, E. Z.; Slusher, B.; Obrosova, I. G. Poly (ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model. Biochem. Pharmacol., 2010, 79, 1007-1014.
132. Obrosova, I. G.; Xu, W.; Lyzogubov, V. V.; Ilnytska, O.; Mashtalir, N.; Vareniuk, I.; Pavlov, I. A.; Zhang, J.; Slusher, B.; Drel, V. R. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic. Biol. Med., 2008, 44, 972-981.
133. Horvath, E. M.; Magenheim, R.; Kugler, E.; Vacz, G.; Szigethy, A.; Levardi, F.; Kollai, M.; Szabo, C.; Lacza, Z. Nitrative stress and poly (ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia, 2009, 52, 1935-1943.
134. Negi, G.; Kumar, A.; Sharma, S. S. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun., 2010, 391, 102-106.
135. Szabo, C. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br. J. Pharmacol., 2009, 156, 713-727.
136. Drel, V. R.; Mashtalir, N.; Ilnytska, O.; Shin, J.; Li, F.; Lyzogubov, V. V.; Obrosova, I. G. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes, 2006, 55, 3335-3343.
137. Obrosova, I. G.; Ilnytska, O.; Lyzogubov, V. V.; Pavlov, I. A.; Mashtalir, N.; Nadler, J. L.; Drel, V. R. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes, 2007, 56, 2598-2608.
138. Obrosova, I. G. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics, 2009, 6, 638-647.
139. Arora, M.; Kumar, A.; Kaundal, R. K.; Sharma, S. S. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy. Eur. J. Pharmacol., 2008, 596, 77-83.
140. Zheng, L.; Kern, T. S. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci., 2009, 14, 3974-3987.
141. Abdelsaid, M. A.; Pillai, B. A.; Matragoon, S.; Prakash, R.; Al-Shabrawey, M.; El-Remessy, A. B. Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J. Pharmacol. Exp. Ther., 2010, 332, 125-134.
142. Vareniuk, I.; Pacher, P.; Pavlov, I. A.; Drel, V. R.; Obrosova, I. G. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency. Int. J. Mol. Med., 2009, 23, 571-580.
143. Ii, M.; Nishimura, H.; Kusano, K. F.; Qin, G.; Yoon, Y. S.; Wecker, A.; Asahara, T.; Losordo, D. W. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation, 2005, 112, 93-102.
144. Hohenstein, B.; Hugo, C. P.; Hausknecht, B.; Boehmer, K. P.; Riess, R. H.; Schmieder, R. E. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol. Dial. Transplant., 2008, 23, 1346-1354.
145. Stadler, K.; Bonini, M. G.; Dallas, S.; Jiang, J.; Radi, R.; Mason, R. P.; Kadiiska, M. B. Involvement of inducible nitric oxide synthase in hydroxyl radical-mediated lipid peroxidation in streptozotocin-induced diabetes. Free Radic. Biol. Med., 2008, 45, 866-874.
146. Perreault, M.; Marette, A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med., 2001, 7, 1138-1143.
147. Dallaire, P.; Bellmann, K.; Laplante, M.; Gelinas, S.; Centeno-Baez, C.; Penfornis, P.; Peyot, M. L.; Latour, M. G.; Lamontagne, J.; Trujillo, M. E.; Scherer, P. E.; Prentki, M.; Deshaies, Y.; Marette, A. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptorgamma agonism. Diabetes, 2008, 57, 1999-2011.
148. Zhou, J.; Huang, K. Peroxynitrite mediates muscle insulin resistance in mice via nitration of IRbeta/IRS-1 and Akt. Toxicol. Appl. Pharmacol., 2009, 241, 101-110.
149. Duplain, H.; Sartori, C.; Dessen, P.; Jayet, P. Y.; Schwab, M.; Bloch, J.; Nicod, P.; Scherrer, U. Stimulation of peroxynitrite catalysis improves insulin sensitivity in high fat diet-fed mice. J. Physiol., 2008, 586, 4011-4016.
150. Charbonneau, A.; Marette, A. iNOS induction underlies lipidinduced hepatic insulin resistance in mice: Potential role of tyrosine nitration of insulin signaling proteins. Diabetes, 2010, 59, 861-871.
151. Nomiyama, T.; Igarashi, Y.; Taka, H.; Mineki, R.; Uchida, T.; Ogihara, T.; Choi, J. B.; Uchino, H.; Tanaka, Y.; Maegawa, H.; Kashiwagi, A.; Murayama, K.; Kawamori, R.; Watada, H. Reduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1. Biochem. Biophys. Res. Commun., 2004, 320, 639-647.
152. Carvalho-Filho, M. A.; Ueno, M.; Hirabara, S. M.; Seabra, A. B.; Carvalheira, J. B.; de Oliveira, M. G.; Velloso, L. A.; Curi, R.; Saad, M. J. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes, 2005, 54, 959-967.
153. Carvalho-Filho, M. A.; Ueno, M.; Carvalheira, J. B.; Velloso, L. A.; Saad, M. J. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am. J. Physiol. Endocrinol. Metab., 2006, 291, E476-482.
154. Gow, A. J.; Duran, D.; Malcolm, S.; Ischiropoulos, H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett., 1996, 385, 63-66.
155. Brito, C.; Naviliat, M.; Tiscornia, A. C.; Vuillier, F.; Gualco, G.; Dighiero, G.; Radi, R.; Cayota, A. M. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J. Immunol., 1999, 162, 3356-3366.
156. MacMillan-Crow, L. A.; Greendorfer, J. S.; Vickers, S. M.; Thompson, J. A. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma. Arch. Biochem. Biophys., 2000, 377, 350-356.
157. Bartesaghi, S.; Peluffo, G.; Zhang, H.; Joseph, J.; Kalyanaraman, B.; Radi, R. Tyrosine nitration, dimerization, and hydroxylation by peroxynitrite in membranes as studied by the hydrophobic probe N-t-BOC-l-tyrosine tert-butyl ester. Methods Enzymol., 2008, 441, 217-236.
158. Bartesaghi, S.; Wenzel, J.; Trujillo, M.; Lopez, M.; Joseph, J.; Kalyanaraman, B.; Radi, R. Lipid Peroxyl Radicals Mediate Tyrosine Dimerization and Nitration in Membranes. Chem. Res. Toxicol., 2010, 23, 821-835.